1Goodyear LJ,Chang PY,Sherwood DJ,et al.Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle [J].Am J Physiol,1996,271(2 Pt 1):E403-E408.
6Wojtaszewski JF,Hansen BF,Kiens B,et al. Insulin signaling in human skeletal muscle: time course and effect of exercise[J].Diabetes,1997,46(11):1775-1981.
2Ebeling, P., etc. Mechanism of enhanced insulin sensitivity in athletes. J. Clin. Invest. 92: 1623～ 1631,1993.
3Qingding Wang,etc. Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway in human colon cancer cells. J. Biol. Chem., Vol. 277, Issue 39, 36602～36610, September 27, 2002 .
4Atef N. Hanna,etc. A novel pathway for tumor necrosis factor-and ceramide signaling involving sequential activation of tyrosine kinase, p21ras, and phosphatidylinositol 3 - kinase. J Biol Chem. Vol. 274,Issue 18, 12722～12729, April 30,1999.
5Sasaoka, T., etc. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras - GTP formarion .(1994)J. Biol. Chem. 269, 10734～10738.
6Jinping Li, etc. Modulation of insulin receptor substrate1 tyrosine phosphorylation by an akt/phosphatidylinositol 3- kinase pathway. J Biol Chem. Vol. 274, Issue 14,9351 - 9356, April 2,1999.
7Haddad, T. C., etc. Insulin and unterleukin- 4 induce desensitization to the mitogenic effects of insulin- like growth factor-I (1997)J. Biol. Chem. 272, 19525～19531.
8Matthew N. Poy, etc. Shc and CEACAM1 interact to regulate the mitogenic action of insulin. J. Biol. Chem.Vol. 277, Issue 2, 1076～1084, January 11, 2002.
9Wojtaszewski, J. F. P. ,etc. Insulin signaling in human skeletal muscle. Diabetes 46: 1775～ 1781, 1997[ Abstract ].
10Zhou, Q., etc. Treadmill running increases phospatidylinositol 3 - kinase activity in rat skeletal muscle. Biochem. Biophys. Res. Comm. 236:647～650, 1997.
